Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin

Abstract Biologic therapies targeting B-cells are emerging as an effective strategy to treat a variety of immune-mediated diseases. One of the most studied B-cell-targeted therapies is rituximab, an anti-CD20 monoclonal antibody that exemplifies B-cell depletion therapy and has served as the prototy...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Ly, Sophia [verfasserIn]

Nedosekin, Dmitry

Wong, Henry K.

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2023

Anmerkung:

© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023

Übergeordnetes Werk:

Enthalten in: American journal of clinical dermatology - Berlin [u.a.] : Springer, 2000, 24(2023), 2 vom: 11. Jan., Seite 247-273

Übergeordnetes Werk:

volume:24 ; year:2023 ; number:2 ; day:11 ; month:01 ; pages:247-273

Links:

Volltext

DOI / URN:

10.1007/s40257-022-00751-7

Katalog-ID:

SPR04946115X

Nicht das Richtige dabei?

Schreiben Sie uns!